This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Herantis Pharma Plc., Helsingin Yliopisto, Myneurocure Oy. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3 
1 out of 12 
1 out of 1 Years Active: 2014-2026
Title: **Innovative Contributions of Merja Voutilainen in Neuronal Disorder Treatments**
Introduction
Merja Voutilainen is a renowned inventor based in Helsinki, Finland. With a profound focus on neurotrophic factors and their applications, she has made significant strides in the treatment of neuronal disorders. Her dedication to innovation has resulted in notable patents that aim to improve the lives of those suffering from various neurological conditions.
Latest Patents
Merja Voutilainen holds two patents that showcase her expertise in the field. Her latest invention, titled *Neurotrophic factor MANF and uses thereof*, relates to the treatment of neuronal disorders. The invention presents a pharmaceutical compound that comprises a MANF nucleic acid molecule, MANF protein, or a functional fragment thereof. This compound is intended for the treatment of peripheral neuropathies, including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction, and ischemic brain injury.
Career Highlights
She is currently affiliated with Herantis Pharma Plc., where she utilizes her knowledge and skills to contribute to cutting-edge research in neurology. Voutilainen's innovative mindset has led to the development of therapeutic solutions aimed at alleviating the symptoms associated with debilitating neurological diseases.
Collaborations
Throughout her career, Merja Voutilainen has collaborated with esteemed professionals in her field, including Mart Saarma and Johan Peränen. These partnerships have fostered a creative environment and have been instrumental in advancing research related to MANF and its applications in treating neuronal disorders.
Conclusion
Merja Voutilainen’s contributions to the field of neuroscience through her inventions and patents are remarkable. Her work in developing therapies targeting serious neurological conditions exemplifies the power of innovation in improving health outcomes for patients. With her ongoing endeavors, Voutilainen continues to make a significant impact in the realm of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile